Clinical Trials Arena

News, views and contacts from the global Clinical industry
15 March 2019
WEEKLY UPDATE
Digital Magazine
Latest Companies

S-CLINICA

EPS International

Aspen Research

Clinical Maestro™

CPI Global CRO

Defence forum on LinkedIn


Join our Defence forum on LinkedIn
NRI digital has launched a LinkedIn group to unite professionals involved in the defence and aerospace industry for the opportunity to network and discuss today's most important technologies and issues. Click here if you have a story to tell, a topic to discuss or just want to build contacts.

White Papers

The Perfect Remedy for Clinical Trial Distribution
Over the past decade, the distribution of Investigational Medicinal Products (IMPs) has become a complex part of the supply chain for companies involved in new drug development. 

Building The Industry’s Most Advanced Modeling Engine
For the past ten years, the industry has seen an increased demand to determine fair market value of CRO and other clinical trial service providers.

Clinical Trials: Enrollment Trends in Emerging Markets – Russia
Scotty Chung-Siu, Brooke Wilson & Revati Tatake, GlobalData, examine developments in the Russian clinical trial space

Clinical Trials: Enrollment Trends in Emerging Markets – Brazil
In an exclusive white paper, Brooke Wilson, Revati Tatake & Bonnie Bain, GlobalData, assess the clinical trial landscape in Brazil

Clinical Trials: Enrollment Trends in Emerging Markets – South Korea
This whitepaper provides a review of Phase I to Phase IV clinical trials with a start date between January 1, 2001 and June 5, 2018, and which have a trial location in South Korea.

Press Releases

Almac Group Announces Almac One™: A Unified Clinical Trial Supply Solution
Almac Group has announced the Almac One™, providing the first unified Clinical Trial Supply solution.

Clinical Maestro adds eProcurement and CRO Edition to Clinical Trial Business Software Suite
Strategikon Pharma has announced the commercial release of its Pharma (Sponsor) Edition SOURCE™ module for automating key processes in clinical outsourcing, as well as its Provider (CRO) Edition CORE™ and LINK™ modules for digital bid costing and third-party sourcing.

Forty-three Countries Across Five Continents – A Global Pharmacovigilance Company

IntuVigilance win major Pharma Industry Award

Product Selection
There are several forces pushing healthcare professionals to provide patients with personalized medicine, in which treatments are tailored to suit the needs of individual patients.

Features

How to Source Non-IMP Supplies for Clinical Trials
Tim Holmes, Manager, Clinical Oversight of Supplies, Biogen, offers considerations on how to obtain non-IMP supplies for clinical trials

Sandoz Abandons US Development of Rixathon
Chloé Thépaut, MRes, Oncology Senior Analyst, GlobalData, examines the implications of Sandoz’s abandoned attempt to have Rixathon approved in the US

GDPR: The Implications for Clinical Development
Eight months in, Nigel Hughes, Scientific Director JCI-PDR, Janssen, examines the ramifications of GDPR on the industry now the regulation has taken effect

DVD previews do not improve clinical trial recruitment, study finds
The inclusion of an audio-visual DVD presentation among study invitation materials does not improve recruitment to clinical trials, a study published in BMC Medical Research Methodology has revealed.

Industry Viewpoints: Patient Recruitment and Expanded Access
In the latest Industry Viewpoint, Howard Fingert speaks to CTA’s Elizabeth Williams about the challenges of patient recruitment

Projects
Follow Us:   Facebook Facebook    Twitter Twitter    LinkedIn LinkedIn    YouTube YouTube   
Click here to unsubscribe from the newsletter | Privacy Policy
You are receiving this email because you are either a valued subscriber to Clinical Trials Arena or have signed up via a partner web site. Your email address has not been, and will not be, given to third parties.

www.clinicaltrialsarena.com is a product of Kable.
Copyright
2019 Kable, a trading division of Kable Intelligence Limited.